mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.07 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.07 |